Achievelifesciences

Late-stage pharma developing cytisinicline, an investigational non-nicotine treatment for adults trying to quit smoking or vaping

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-14

Recent signals

What changed at Achievelifesciences in the last 6 months, newest first. Each line links to its public source.

Get signals like these for the companies you sell to →

About Achievelifesciences

AchieveRx, The Quit Company, is a late-stage pharmaceutical company developing cytisinicline, an investigational compound that binds to nicotinic receptors, including the α4β2 receptor most closely linked to nicotine dependence. Cytisinicline contains no nicotine. It is not approved by the FDA and is not yet available for use.

The company's clinical program covers smoking cessation and vaping cessation. Its ORCA trials were conducted in the U.S. and enrolled adults who smoke or vape and want to quit, including people who had tried other treatments. The vaping program holds FDA Breakthrough Therapy designation and a Commissioner's National Priority Voucher.

The company was formerly known as Achieve Life Sciences and was renamed AchieveRx, The Quit Company, with its shares to trade under the ticker QUIT. Andrew D. Goldberg, MD, was appointed Chief Executive Officer in April 2026. Open roles are concentrated in U.S. commercial, medical, quality and finance functions.

Product: Cytisinicline, an investigational nicotinic receptor treatment in late-stage trials for smoking cessation and vaping cessation; not FDA-approved.

Jobs at Achievelifesciences

No open positions in Europe right now.

Open roles at Achievelifesciences in the Americas (2)

United States 2. From Achievelifesciences's careers page or applicant tracking system; each role links to the employer.

More biotech & pharma companies

  • Achira

    Atomistic foundation simulation models for drug discovery and other physical-science applications
    United StatesBiotech & pharma
    New on Evolc
  • Adaptive Biotechnologies

    Immune-receptor sequencing and data products for clinicians and biopharmaceutical companies developing and testing therapies
    United StatesBiotech & pharma
    New on Evolc
  • Aditum Bio

    Biotech venture and operating firm that forms companies to develop drug candidates into medicines for patients
    Oakland, United StatesBiotech & pharma
    New on Evolc
  • Agcbio

    Contract development and manufacturing services for biopharmaceutical companies developing biologics and advanced therapies
    Bothell, United StatesBiotech & pharmaFounded 201835 open jobs
    New on Evolc
  • AION Biosciences

    Bioelectricity tools and medical devices for individuals seeking greater control over their biology
    United StatesBiotech & pharma
    New on Evolc
  • Alltrna

    Engineered tRNA medicines for patients with genetic diseases caused by disrupted protein production
    United StatesBiotech & pharma
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content delivery

Content management

  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Gravity FormsHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Recruiting

  • BambooHRMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.